RE:RE:RE:RE:Phase 1 Colorectal Cancer demonstrated 93% clinical benefit @buck. Thank you so much. You prompted me to look up something that clarifies the status of GOBLET; at least for me. I had forgotten about the following. ONC/ONCY release March 31, 2022. I do not know how to post a release so I shall leave that for another.
The gist is as follows. As of the above date the safety run-in for Cohort 3 (3 patients) had been successfully completed. Cohort 2 and 4 did not include safety run-ins so all 4 cohorts were full steam ahead. Pancreatic we have some news. The other 3 cohorts cannot be far behind. I do not want to sound like a pumper (I know how difficult it is to bring these trials home) so all I shall say is that there has been a cocoon around GOBLET and that is likely a good thing. Cheers